Speaker

Alaina Ownbey

Vice President, Finance & Accounting, Elicio Therapeutics, Inc.

Alaina Ownbey, Vice President, Finance & Accounting at Elicio Therapeutics, Inc., spoke at Finance & Accounting for Bioscience (Boston, United States of America, 24–25 Sept 2026) in the session “Financial Readiness for Commercialization: Forecasting, Modeling and Product Launch Strategies”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

Finance & Accounting for Bioscience
24–25 Sept 2026Boston, United States of America
- SpeakerFinancial Readiness for Commercialization: Forecasting, Modeling and Product Launch StrategiesWith Derek Thomas, Juan Betanzo

More speakers at Finance & Accounting for Bioscience

Maricel Apuli
Chief Accounting Officer, BridgeBio
Maggie Berkeley
Biopharma Sector Leader and Risk Advisory Principal, RSM US LLP
Kwame Boateng
Independent
Kathleen Borthwick
Chief Financial Officer, Passage Bio
Melissa Bradford-Klug
Chief Financial & Business Officer, NorthSea Therapeutics
Jen Cadigan
Partner & Life Sciences Lead, CrossCountry Consulting

See all 39 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Alaina Ownbey, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].